Freeline Therapeutics
Eileen McNeill is a highly experienced Senior Director at Freeline, leading gene therapy projects and providing strategic direction within the Research department. With a background in inflammation, immunology, and cardiovascular disease, Eileen has a strong research and project management skillset, demonstrated through various roles at reputable institutions such as University of Oxford and Cancer Research UK. Eileen's expertise in scientific planning, communication, and teaching makes their a valuable asset in the field of medical sciences.
This person is not in any offices
Freeline Therapeutics
Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.